Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial compliance: implications for clinical practice

P Rudd1

  • 1Department of Medicine, Stanford University Medical Center, California 94305-5475.

Journal of Cardiovascular Pharmacology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Problems in consultation medicine : The generalist's reply.

Journal of general internal medicine·2016
Same author

Deficiencies in education and experience in the management of acute kidney injury among Malawian healthcare workers.

Malawi medical journal : the journal of Medical Association of Malawi·2015
Same author

Is there a place for "drive thru" management of neonatal fever? Not yet!

Archives of disease in childhood. Fetal and neonatal edition·2006
Same author

An evaluation of the PAxpress pharyngeal airway.

Anaesthesia·2003
Same author

Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.

The Journal of biological chemistry·2001
Same author

Involvement of Smads in TGFbeta1-induced furin (fur) transcription.

Journal of cellular physiology·2001
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Patient medication adherence varies significantly, with underdosing being common and hard to predict. Developing longer-acting drugs may improve therapeutic outcomes by compensating for missed doses.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Patient Adherence Research

Background:

  • Assessing clinical response requires integrating patient medication-taking behavior.
  • Automatic treatment escalation risks adverse events and should be avoided.
  • Medication adherence is complex, with significant individual variability.

Purpose of the Study:

  • To highlight the importance of patient medication-taking behavior in therapeutic outcomes.
  • To discourage automatic drug regimen escalation when treatment goals are unmet.
  • To explore strategies for improving medication adherence and therapeutic sufficiency.

Main Methods:

  • Utilizing dynamic measures like electronic monitors to study medication-taking behavior.
  • Analyzing patterns of deviation from prescribed medication regimens.

Related Experiment Videos

  • Evaluating the impact of dosing frequency on compliance.

    • Main Results:

    • Medication-taking behavior exhibits substantial inter- and intra-subject variability.
    • Most deviations are random underdosings, difficult to detect and predict.
    • Compliance decreases with dosing frequencies higher than once daily.
    • Partial compliance in hypertension increases rehospitalization and coronary event rates.

    Conclusions:

    • Accurate assessment of medication-taking behavior is crucial for modern therapeutics.
    • Longer-acting medications offer a strategy to enhance therapeutic sufficiency, compensating for dosing lapses.
    • Focusing on therapeutic sufficiency, rather than strict adherence, may improve patient outcomes.